US 9896502
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 9896502 (Antagonist antibodies directed against calcitonin gene-related peptide and methods using same) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Grant date
- Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61P, A61P25/04